November 30, 2015: Markets opened higher on Monday but the upbeat start to the day didn’t last long. Industrials and consumer discretionary stocks weighed most heavily on equity indexes today, with energy…
November 27, 2015: Markets opened mixed on Friday but only narrowly up or down from Wednesday’s close. No economic data was due out today and there was little corporate news as well.…
Despite the howling from political candidates trying to make the top drug-makers their whipping boy in populist campaign efforts, the need and demand for pharmaceuticals will only continue. This is especially the case…
Tuesday's top analyst upgrades, downgrades and initiations include Antero Resources, Athenahealth, Capstone Turbine, Clovis Oncology, Genworth Financial, Merck, Nuance Communications and Salesforce.com.
Merck is joining the likes of Gilead Sciences in producing hepatitis C vaccines, but it is still in the early clinical stages.
November 11, 2015: Markets opened up on Wednesday but over the course of the day the markets drifted lower to close the day marginally negative. The dollar gained only slightly while equities…
The short interest data have been released for the October 30 settlement date, and for most of the selected pharmaceutical stocks, short interest was down.
ThinkstockOctober 28, 2015: Markets opened higher on Wednesday and bounced of intra-day lows following the FOMC announcement which led investors to believe that interest rates may rise in December. Energy markets were…
Pfizer and Merck both released their third-quarter earnings on Tuesday morning. So, which drug giant is looking better after earnings?
The October 15 short interest data have been compared with the previous figures, and for most of the selected pharmaceutical stocks, short interest was mixed.
Merckis expected to report its third-quarter financial results before the markets open on Tuesday.
Chris Lange 24/7 Wall St. has put together a preview of Apple, Exxon and some of the major Dow Jones Industrial Average companies that are reporting their quarterly results this week.
24/7 Wall St. screened the Merrill Lynch research universe for pharmaceutical stocks paying solid dividends that are rated Buy, and found four outstanding companies.
ThinkstockOctober 22, 2015: Markets opened higher on Thursday on a better-than-expected report on new claims for unemployment benefits, but the better news for investors is that European Central Bank is ready to…
ThinkstockOctober 20, 2015: Markets opened lower on again on Tuesday as investors trailed along after mixed Asian and European equities markets. In Europe prospects for further central bank easing dimmed, while in…
